Repligen Company
![](/storage/logos_100px/Repligen.jpeg)
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Technology:
Others
Industry:
PharmTech
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
1981-01-01
Employees Number:
1001-5000
Funding Status:
IPO
Total Funding:
918225000
Estimated Revenue:
$50M to $100M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership